Articles in Scholarly Journals [Incomplete List]

1. Peripheral Mononuclear Cell Resistin mRNA Expression Is Increased in Type 2 Diabetic Women
   Mediators of Inflammation, vol. 2008, Article ID 892864, 8 pages, 2008
2. IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism
   European Journal of Endocrinology, vol. 158, no. 3, pp. 361–366, 2008
3. Insulin-Stimulated Rates of Glucose Uptake in Muscle in Hyperthyroidism: The Importance of Blood Flow
   Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 6, pp. 2413–2415, 2008
4. Impaired Postprandial Blood Flow in Adipose Tissue May Be an Early Marker of Insulin Resistance in Type 2 Diabetes
   Diabetes Care, vol. 30, no. 12, pp. 3128–3130, 2007
5. The Importance of Adipose Tissue in Diabetes Pathophysiology and Treatment
   Hormone and Metabolic Research, vol. 39, no. 10, pp. 705–706, 2007
6. Glucose transporter expression on the plasma membrane of resting and activated white blood cells
   European Journal of Clinical Investigation, vol. 37, no. 4, pp. 282–290, 2007
7. Visfatin, TNF-α and IL-6 mRNA Expression is Increased in Mononuclear Cells from Type 2 Diabetic Women
   Hormone and Metabolic Research, vol. 39, no. 10, pp. 758–763, 2007
8. Intermediate Postchallenge Hyperglycemia in Overweight and Obese Subjects: A New Marker of Impaired Glucose Regulation?
   Angiology, vol. 57, no. 6, pp. 709–716, 2007
9. Once-daily Insulin Glargine Administration in the Morning Compared to Bedtime in Combination with Morning Glimepiride in Patients with Type 2 Diabetes: An Assessment of Treatment Flexibility
   Hormone and Metabolic Research, vol. 38, no. 3, pp. 172–177, 2006
10. Bone mineral density of both genders in Type 1 diabetes according to bone composition
    Journal of Diabetes and its Complications, vol. 20, no. 5, pp. 302–307, 2006
11. Discrepancies between vertebral bone density values: The least dense vertebra
    Maturitas, vol. 53, no. 4, pp. 476–482, 2006
12. Erratum to “Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysis” [Nutr Metab Cardiovasc Dis 15 (1) (2005) 6–12]
    Nutrition, Metabolism and Cardiovascular Diseases, vol. 16, no. 1, pp. 81–81, 2006
13. Metabolism, vol. 55, no. 2, pp. 278–278, 2006
14. Metabolic Syndrome and Prediabetes Identify Overlapping But Not Identical Populations
    Experimental and Clinical Endocrinology & Diabetes, vol. 114, no. 7, pp. 377–383, 2006
15. Insulin Resistance and Blood Pressure Circadian Variation in an Obese Hypertensive Population
    Clinical and Experimental Hypertension, vol. 28, no. 7, pp. 625–630, 2006
16. Insulin Action in Adipose Tissue and Muscle in Hypothyroidism
    Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 12, pp. 4930–4937, 2006
17. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia
    European Journal of Haematology, vol. 76, no. 3, pp. 230–236, 2006
18. Perinuclear antineutrophil cytoplasmic antibody myeloperoxidase-positive vasculitis in association with ulcerative colitis
    Clinical Rheumatology, vol. 25, no. 1, pp. 35–37, 2006
19. Impaired effect of endothelin-1 on coronary artery stiffness in type 2 diabetes
    International Journal of Cardiology, vol. 112, no. 2, pp. 207–212, 2006
20. Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry
    Cytometry Part A, vol. 64A, no. 1, pp. 27–33, 2005
21. Measurement of hepatic venous pressure gradient in patients with active variceal bleeding
    Hepatology, vol. 41, no. 2, pp. 406–407, 2005
22. Cell turnover of serrated adenomas
    The Journal of Pathology, vol. 206, no. 1, pp. 62–67, 2005
23. Glucose and Lipid Fluxes in the Adipose Tissue after Meal Ingestion in Hyperthyroidism
    Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 3, pp. 1112–1118, 2005
24. Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial
    Annals of Oncology, vol. 16, no. 2, pp. 294–299, 2005
25. Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation
    Alimentary Pharmacology and Therapeutics, vol. 21, no. 12, pp. 1435–1443, 2005
26. Diabetes and premature menopause: is their co-existence detrimental to the skeleton?
    European Journal of Endocrinology, vol. 152, no. 3, pp. 437–442, 2005
27. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer
    Journal of Pharmaceutical and Biomedical Analysis, vol. 37, no. 1, pp. 171–176, 2005
28. Thyroid Hormone Excess Increases Basal and Insulin-stimulated Recruitment of GLUT3 Glucose Transporters on Cell Surface
    Hormone and Metabolic Research, vol. 37, no. 1, pp. 15–20, 2005
29. Acute myelogenous leukemia with tetrasomy 8 is a disease with a poor prognosis
    Cancer Genetics and Cytogenetics, vol. 161, no. 1, pp. 78–81, 2005
30. Correlation between intracellular interferon-γ (IFN-γ) production by CD4+ and CD8+ lymphocytes and IFN-γ gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA)
    Cytokine, vol. 31, no. 2, pp. 135–141, 2005
31. A novel p27 gene mutation in a case of unclassified myeloproliferative disorder
    Leukemia Research, vol. 29, no. 2, pp. 229–231, 2005
32. Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis
    Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 1, pp. 6–12, 2005
33. Expression of Leptin Receptors in Mononuclear Cells from Myelodysplastic Syndromes and Acute Myeloid Leukemias
    Acta Haematologica, vol. 114, no. 2, pp. 71–77, 2005
34. Good Glycemic Control With Flexibility in Timing of Basal Insulin Supply: A 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride
    Diabetes Care, vol. 28, no. 2, pp. 419–420, 2005
35. Intracellular IFN- Production and IL-12 Serum Levels in Latent Autoimmune Diabetes of Adults (LADA) and in Type 2 Diabetes
    Journal of Interferon Cytokine Research, vol. 24, no. 7, pp. 381–387, 2004
36. Molecular cytogenetic analysis of breast cancer: a combined multicolor fluorescence in situ hybridization and G-banding study of uncultured tumor cells
    Cancer Genetics and Cytogenetics, vol. 149, no. 1, pp. 28–37, 2004
37. Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization
    Cancer Genetics and Cytogenetics, vol. 149, no. 2, pp. 107–113, 2004
38. Oxaliplatin and Irinotecan plus Granulocyte-Colony Stimulating Factor as Third-Line Treatment in Relapsed or Cisplatin-Refractory Germ-Cell Tumor Patients:A Phase II Study
    European Urology, vol. 46, no. 2, pp. 216–221, 2004
39. Impaired Erythrocyte Deformability Precedes Vascular Changes in Experimental Diabetes Mellitus
    Hormone and Metabolic Research, vol. 36, no. 3, pp. 142–147, 2004
40. Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: A phase II study
    Gynecologic Oncology, vol. 95, no. 1, pp. 165–172, 2004
41. Individualized Risk Management in Diabetics: How to Implement Best Practice Guidelines – Design and Concept of the IRIDIEM Studies
    Kidney and Blood Pressure Research, vol. 27, no. 3, pp. 127–133, 2004
42. Photodynamic Therapy in Normal Pig Stomach: Protective Effect of Octreotide
    Endoscopy, vol. 36, no. 10, pp. 893–897, 2004
43. Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism
    European Journal of Clinical Investigation, vol. 34, no. 7, pp. 490–497, 2004
44. Differential Effects of High-fat and High-carbohydrate Content Isoenergetic Meals on Plasma Active Ghrelin Concentrations in Lean and Obese Women
    Hormone and Metabolic Research, vol. 36, no. 8, pp. 559–563, 2004
45. Absence of MLL gene rearrangement in de novo myelodysplastic syndromes (MDS)
    Annals of Hematology, vol. 83, no. 3, pp. 170–175, 2004
46. Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice
    Diabetes/Metabolism Research and Reviews, vol. 20, no. S2, pp. S13–S23, 2004
47. TNF-?, TGF-?1, IL-10, IL-6, Gene Polymorphisms in Latent Autoimmune Diabetes of Adults (LADA) and Type 2 Diabetes Mellitus
    Journal of Clinical Immunology, vol. 24, no. 6, pp. 591–599, 2004
48. Novel constitutional translocations t(3;5)(p25;q22) and t(1;14)(p31;q21) in patients with acute leukemia
    Annals of Hematology, vol. 83, no. 3, pp. 156–159, 2004
49. Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review
    Annals of Hematology, vol. 83, no. 3, pp. 153–155, 2004
50. M-FISH in gastric lymphoma
    Cancer Genetics and Cytogenetics, vol. 155, no. 1, pp. 63–66, 2004
51. Bone density patterns after normal and premature menopause
    Maturitas, vol. 44, no. 4, pp. 279–286, 2003
52. Monoclonal gammopathies in B-cell non-Hodgkin's lymphomas
    Leukemia Research, vol. 27, no. 6, pp. 505–508, 2003
53. Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma A pilot study
    Leukemia Research, vol. 27, no. 12, pp. 1097–1099, 2003
54. Clearing the stomach before emergency endoscopy in cirrhotics with acute upper gastrointestinal bleeding. A gastrokinetic or a vasoactive drug?
    Journal of Hepatology, vol. 39, no. 1, pp. 130–131, 2003
55. Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy
    Clinical Drug Investigation, vol. 23, no. 10, pp. 679–686, 2003
56. Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study
    European Journal of Haematology, vol. 71, no. 4, pp. 257–262, 2003
57. Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?
    Clinical Endocrinology, vol. 58, no. 1, pp. 72–77, 2003
58. Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women
    Metabolism, vol. 52, no. 11, pp. 1426–1432, 2003
59. Performance of Two Immunosorbent Assay Kits for the Detection of Serum Immunoglobulin G to Helicobacter pylori in Untreated Greek Patients
    Scandinavian Journal of Gastroenterology, vol. 37, no. 5, pp. 512–516, 2002
60. Annals of Surgery, vol. 236, no. 6, pp. 806–813, 2002
61. Application of multiplex fluorescence in situ hybridization in the cytogenetic analysis of primary gastric carcinoma
    Cancer Genetics and Cytogenetics, vol. 135, no. 1, pp. 23–27, 2002
62. Percutaneous Endoscopic Gastrostomy: Adequacy and Quality of Information Given to Decision-Makers
    Digestive Diseases, vol. 20, no. 3-4, pp. 289–292, 2002
63. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: A multicenter randomized controlled trial
    Gastrointestinal Endoscopy, vol. 55, no. 4, pp. 470–475, 2002
64. Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies
    Alimentary Pharmacology and Therapeutics, vol. 16, no. 3, pp. 569–575, 2002
65. Flow cytometric detection of intracellular IL-12 release: in vitro effect of widely used immunosuppressants
    International Immunopharmacology, vol. 2, no. 12, pp. 1713–1720, 2002
66. Visceral Leishmaniasis (Kala-Azar) in bone marrow aspirate
    European Journal of Haematology, vol. 68, no. 6, pp. 400–400, 2002
67. Evaluation of a Single-Step Serological Assay for Laboratory Diagnosis of Helicobacter pylori Infection
    European Journal of Clinical Microbiology & Infectious Diseases, vol. 21, no. 1, pp. 56–59, 2002
68. The Desmopressin and Combined CRH-Desmopressin Tests in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome: Constraints Imposed by the Expression of V2 Vasopressin Receptors in Tumors with Ectopic ACTH Secretion
    Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 4, pp. 1646–1653, 2002
69. European Journal of Gastroenterology & Hepatology, vol. 14, no. 7, pp. 801–803, 2002
70. T-Cell-Rich B-Cell Lymphoma
    Oncology, vol. 61, no. 4, pp. 257–264, 2001
71. Massive hemothorax due to intrathoracic extramedullary hematopoiesis in a patient with hereditary spherocytosis
    Annals of Hematology, vol. 80, no. 1, pp. 38–40, 2001
72. TNFα and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells
    International Journal of Obesity, vol. 25, no. 7, Article ID 0801657, 8 pages, 2001
73. Digestive Diseases and Sciences, vol. 46, no. 7, pp. 1567–1572, 2001
74. Toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds
    European Journal of Internal Medicine, vol. 12, no. 5, pp. 406–411, 2001
75. The association between CagA status and the development of esophagitis after the eradication of helicobacter pylori
    The American Journal of Medicine, vol. 110, no. 9, pp. 703–707, 2001
76. Efficacy of Intravenous Immunoglobulin in the Treatment of Thrombotic Thrombocytopaenic Purpura
    Acta Haematologica, vol. 105, no. 4, pp. 204–208, 2001
77. Preface of Guest Editors
    Experimental and Clinical Endocrinology & Diabetes, vol. 109, no. Suppl 2, p. S81, 2001
78. Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics
    Diabetes Research and Clinical Practice, vol. 51, no. 3, pp. 205–213, 2001
79. Oral hypoglycemic agents: insulin secretagogues, α-glucosidase inhibitors and insulin sensitizers
    Experimental and Clinical Endocrinology & Diabetes, vol. 109, no. Suppl 2, pp. S265–S287, 2001
80. Splenectomy in patients with malignant non-Hodgkin's lymphoma
    European Journal of Haematology, vol. 64, no. 3, pp. 145–150, 2000
81. Screening for diabetes in obese women: comparison between the New American Diabetes Association and WHO criteria
    Clinical Endocrinology, vol. 52, no. 2, pp. 248–250, 2000
82. Appropriate Timing of Glimepiride Administration in Patients with Type 2 Diabetes Millitus: A Study in Mediterranean Countries
    Endocrine, vol. 13, no. 1, pp. 117–122, 2000
83. Expression of the long and short leptin receptor isoforms in peripheral blood mononuclear cells: Implications for leptin's actions
    Metabolism, vol. 49, no. 12, pp. 1537–1541, 2000
84. Digestive Diseases and Sciences, vol. 45, no. 1, pp. 63–67, 2000
85. Digestive Diseases and Sciences, vol. 45, no. 12, pp. 2357–2362, 2000
86. Letters to the Editor Two different doses and duration schedules of somatostatin -14 in the treatment of patients with bleeding oesophageal varices: a non-randomised controlled study
    Journal of Hepatology, vol. 32, no. 1, pp. 171–172, 2000
87. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases
    Annals of Hematology, vol. 79, no. 2, pp. 66–72, 2000
88. Mutations of the ACTH Receptor Gene in a New Family with Isolated Glucocorticoid Deficiency
    Molecular Genetics and Metabolism, vol. 71, no. 4, pp. 646–650, 2000
89. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring
    The American Journal of Gastroenterology, vol. 95, no. 2, pp. 374–380, 2000
90. Spontaneous remission in myelodysplastic syndrome
    Annals of Hematology, vol. 78, no. 2, pp. 89–90, 1999
91. Internal medicine in Greece
    European Journal of Internal Medicine, vol. 10, no. 4, pp. 225–228, 1999
92. Digestive Diseases and Sciences, vol. 44, no. 6, pp. 1156–1160, 1999
93. Digestive Diseases and Sciences, vol. 44, no. 3, pp. 487–493, 1999
94. Dose-Dependent Effects of Recombinant Human Interleukin-6 on the Pituitary-Testicular Axis
    Journal of Interferon Cytokine Research, vol. 19, no. 11, pp. 1271–1276, 1999
95. The type and time of menopause as decisive factors for bone mass changes
    European Journal of Clinical Investigation, vol. 29, no. 10, pp. 877–885, 1999
96. Honey, Fructose, Absorption and the Laxative Effect
    Nutrition, vol. 15, no. 7-8, pp. 591–592, 1999
97. Relationship of Helicobacter pylori CagA(+) status to gastric juice vitamin C levels
    European Journal of Clinical Investigation, vol. 29, no. 1, pp. 56–62, 1999
98. Acquisition of Competence in Colonoscopy: The Learning Curve of Trainees
    Endoscopy, vol. 31, no. 9, pp. 702–706, 1999
99. Comparative in vitro and in vivo efficacy of roxithromycin and erythromycin against a strain of methicillin-susceptible Staphylococcus epidermidis
    Diagnostic Microbiology and Infectious Disease, vol. 32, no. 1, pp. 51–54, 1998
100. Long-term effectiveness of a new α-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated Type 2 diabetes mellitus
     Diabetic Medicine, vol. 15, no. 8, pp. 657–660, 1998
101. Furosemide decreases the sensitivity of glucose transport to insulin in skeletal muscle in vitro
     European Journal of Endocrinology, vol. 139, no. 1, pp. 118–122, 1998
102. Codon 12 ras mutations in patients with myelodysplastic syndrome: incidence and prognostic value
     Annals of Hematology, vol. 74, no. 1, pp. 11–14, 1997
103. Coronary microcirculation evaluation with transesophageal echocardiography Doppler in type II diabetics
     International Journal of Cardiology, vol. 59, no. 2, pp. 119–124, 1997
104. Anterior, posterior, or laparoscopic approach for the management of adrenal diseases?
     The American Journal of Surgery, vol. 173, no. 2, pp. 120–125, 1997
105. Helicobacter pylori may induce bile reflux: link between H pylori and bile induced injury to gastric epithelium.
     Gut, vol. 38, no. 1, pp. 15–18, 1996
106. Cytogenetic findings in a Fanconi anemia patient with AML
     Cancer Genetics and Cytogenetics, vol. 90, no. 2, pp. 182–183, 1996
107. Adrenaloma: A Call for More Aggressive Management
     World Journal of Surgery, vol. 20, no. 7, pp. 788–793, 1996
108. Perendoscopic Watson capsule biopsy of the jejunum: A simple, effective, safe method which does not require fluoroscopy
     Gastrointestinal Endoscopy, vol. 41, no. 1, pp. 80–82, 1995
109. Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome*1
     Metabolism, vol. 44, no. 4, pp. 525–531, 1995
110. Somatostatin or octreotide versus endscopic sclerotheraphy in acute variceal haemorraghe: a meta-analysis study
     Journal of Hepatology, vol. 22, no. 2, pp. 247–251, 1995
111. The effect of somatostatin and octreotide on intravascular oesophageal variceal pressure in patients with cirrhosis
     Journal of Hepatology, vol. 22, no. 3, pp. 379–380, 1995
112. δ-Aminolaevulinic acid dehydratase as an index of lead toxicity. Time for a reappraisal?
     European Journal of Clinical Investigation, vol. 25, no. 1, pp. 53–58, 1995
113. Does acromegaly really predispose to an increased prevalence of gastrointestinal tumours?
     Clinical Endocrinology, vol. 41, no. 5, pp. 597–601, 1994
114. Antiphospholipid Syndrome: Clinical and Therapeutic Aspects
     Lupus, vol. 3, no. 2, pp. 91–96, 1994
115. Reversibility of Unawareness of Hypoglycemia in Patients with Insulinomas
     New England Journal of Medicine, vol. 329, no. 12, pp. 834–839, 1993
116. Complex carbohydrate malabsorption in exocrine pancreatic insufficiency.
     Gut, vol. 34, no. 7, pp. 984–987, 1993
117. Zidovudine-responsive pure red cell aplasia as initial manifestation of HIV infection
     AIDS, vol. 7, no. 2, p. 290, 1993
118. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial
     Journal of Hepatology, vol. 19, no. 2, pp. 301–311, 1993
119. The effect of an eucaloric high carbohydrate diet on circulating levels of glucose, fructose and non-esterified fatty acids in patients with cirrhosis
     Journal of Hepatology, vol. 14, no. 1, pp. 78–87, 1992
120. Changes in serum lipids and lipoproteins in cancer patients during chemotherapy
     Cancer Chemotherapy and Pharmacology, vol. 30, no. 5, pp. 412–416, 1992
121. Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans.
     Gut, vol. 33, no. 9, pp. 1246–1248, 1992
122. Pulsatile human corticotropin-releasing hormone prevents dexamethasone- induced suppression of the plasma cortisol response to hypoglycemia in normal men
     Journal of Clinical Endocrinology & Metabolism, vol. 75, no. 5, pp. 1358–1361, 1992
123. Globin chain synthesis in myelodysplastic syndromes.
     Journal of Clinical Pathology, vol. 44, no. 2, pp. 134–138, 1991
124. A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage1
     Journal of Hepatology, vol. 13, no. 1, pp. 78–83, 1991
125. Isochromosome (17q) in Ph-negative chronic myelocytic leukemia
     Cancer Genetics and Cytogenetics, vol. 49, no. 2, pp. 271–272, 1990
126. Primary gastric lymphoma
     European Journal of Cancer and Clinical Oncology, vol. 26, no. 7, p. 855, 1990
127. Monoclonal gammopathy in chronic myeloproliferative disorders
     Blut, vol. 58, no. 1, pp. 7–9, 1989
128. Invasive balantidiasis presented as chronic colitis and lung involvement
     Digestive Diseases and Sciences, vol. 34, no. 10, pp. 1621–1623, 1989
129. Reproducible lactulose hydrogen breath test as a measure of mouth-to-cecum transit time
     Digestive Diseases and Sciences, vol. 34, no. 6, pp. 919–924, 1989
130. Effect of isoniazid, a haem inhibitor, on globin chain synthesis in reticulocytes from non-thalassaemic and beta thalassaemic subjects.
     Journal of Clinical Pathology, vol. 42, no. 9, pp. 977–981, 1989
131. Effects of prolonged administration of two new a-glucosidase inhibitors on blood glucose control, insulin requirements and breath hydrogen excretion in patients with insulin-dependent diabetes mellitus
     European Journal of Clinical Investigation, vol. 18, no. 1, pp. 33–38, 1988
132. Cytogenetic study of rectosigmoidal adenocarcinomas
     Cancer Genetics and Cytogenetics, vol. 34, no. 1, pp. 101–109, 1988
133. The effects of the somatostatin analogue SMS 201-995 on carbohydrate homeostasis of insulin-dependent diabetics as assessed by the artificial endocrine pancreas
     Diabetes Research and Clinical Practice, vol. 5, no. 2, pp. 91–98, 1988
134. Plasma lipid and lipoprotein response to carbohydrate feeding in cirrhotic patients
     Journal of Hepatology, vol. 6, no. 3, pp. 315–324, 1988
135. Common cytogenetic findings in gastric cancer
     Cancer Genetics and Cytogenetics, vol. 24, no. 1, pp. 63–73, 1987
136. Cytogenetic findings in a large bowel adenocarcinoma
     Cancer Genetics and Cytogenetics, vol. 21, no. 4, pp. 361–364, 1986
137. Effects of two new α-glucosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus
     Klinische Wochenschrift, vol. 64, no. 9, pp. 405–410, 1986
138. HETEROGENEITY OF GROWTH-HORMONE DEFICIENCY
     The Lancet, vol. 325, no. 8425, pp. 399–400, 1985
139. G-banded karyotype of a primary renal-cell carcinoma
     Cancer Genetics and Cytogenetics, vol. 11, no. 2, pp. 227–232, 1984
140. Synthetic human gastrin I and gastrin-like pentapeptide in studies of intestinal absorption in man
     Research in Experimental Medicine, vol. 180, no. 3, pp. 223–228, 1982
141. Effects of secretin and cholecystokinin-pancreocymin on water, electrolyte and glucose absorption in human jejunum
     Research in Experimental Medicine, vol. 180, no. 3, pp. 215–221, 1982
142. Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man
     European Journal of Clinical Pharmacology, vol. 20, no. 1, pp. 17–22, 1981
143. SOMATOSTATIN IN PEPTIC ULCER
     The Lancet, vol. 315, no. 8180, p. 1248, 1980
144. Immunoreactivity of the endocrine pancreas. Evidence for the presence of cholecystokinin-pancreozymin within the A-cell
     Histochemistry, vol. 56, no. 1, pp. 13–35, 1978
145. Humanes C-Peptid
     Klinische Wochenschrift, vol. 56, no. 3, pp. 111–120, 1978
146. Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones*1
     Metabolism, vol. 27, no. 9, pp. 1321–1328, 1978
147. Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin*1
     Metabolism, vol. 27, no. 9, pp. 1269–1273, 1978
148. Hemodynamic and renin responses to somatostatin in essential hypertension
     Metabolism, vol. 27, no. 9, pp. 1361–1363, 1978
149. Estimation of cholecystokinin-pancreozymin (CCK) in human plasma and tissue by a specific radioimmunoassay and the immunohistochemical identification of pancreozymin-producing cells in the duodenum of humans
     Clinica Chimica Acta, vol. 80, no. 2, pp. 305–316, 1977
150. PREVENTION BY SOMATOSTATIN OF RISE IN BLOOD PRESSURE AND PLASMA RENIN MEDIATED BY BETA-RECEPTOR STIMULATION
     Clinical Endocrinology, vol. 6, no. 6, pp. 455–462, 1977
151. INHIBITION OF FRUSEMIDE-INDUCED HYPERRENINqMIA BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN MAN
     The Lancet, vol. 307, no. 7963, pp. 772–774, 1976
152. A reliable method for generating antibodies against pancreozymin, secretin and gastrin
     Clinica Chimica Acta, vol. 73, no. 3, pp. 439–444, 1976
153. Coagulation studies and platelet function after somatostatin infusion
     Klinische Wochenschrift, vol. 54, no. 20, pp. 977–982, 1976
154. 145. Langzeitbehandlung mit Somatostatin bei der Ulcusblutung des Risikopatienten
     Langenbecks Archiv f�r Chirurgie, vol. 342, no. 1, pp. 604–604, 1976
155. Prevention of stress ulcer by Somatostatin in rats
     Langenbecks Archiv f�r Chirurgie, vol. 341, no. 4, pp. 297–301, 1976
156. Hypergastrinemia induced by glucocorticoid and corticotropin treatment in man
     The American Journal of Digestive Diseases, vol. 21, no. 5, pp. 376–380, 1976
157. Effect of Lipids on Insulin, Growth Hormone and Exocrine Pancreatic Secretion in Man
     European Journal of Clinical Investigation, vol. 5, no. 1, pp. 521–526, 1975
158. The Effect of the β-Receptor Blockade (Propranolol) on the Endocrine and Exocrine Pancreatic Function in Man after the Administration of Intestinal Hormones (Secretin and Cholecystokinin-Pancreozymin)
     European Journal of Clinical Investigation, vol. 3, no. 3, pp. 163–168, 1973
159. The influence of l-(5-oxohexyl-)3.7-dimethylxanthine (BL 191) on the endocrine and exocrine pancreatic function in man during and following secretin and cholecystokinin-pancreozymin stimulation
     Research in Experimental Medicine, vol. 161, no. 4, pp. 327–334, 1973
160. The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones
     Diabetologia, vol. 7, no. 1, pp. 1–5, 1971
161. Disaccharidasenaktivit�t des jejunums subtotal pankreatektomierter rattenActivity of maltase, sucrase, and lactase, in the jejunum of subtotally (95%) pancreatectomized rats
     Clinica Chimica Acta, vol. 33, no. 1, pp. 61–67, 1971